SCHEMBL21035640

SCHEMBL21035640

NC1CC2CCC(C1)N2C(=O)[C@@H]1CN(Cc2ccc(C3(C(F)(F)F)CC3)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.35
MMP13 P45452 4/20 0.35
MMP9 P14780 3/20 0.35
MMP3 P08254 1/20 0.35
MMP7 P09237 1/20 0.35
CCR4 P51679 3/20 0.35
NAMPT P43490 1/20 0.33
ROCK1 Q13464 3/20 0.33
ROCK2 O75116 2/20 0.33
FAAH O00519 1/20 0.33
ADAM17 P78536 2/20 0.32
CCR2 P41597 1/20 0.32
CYP3A4 P08684 2/20 0.32
UGCG Q16739 2/20 0.32
ITGB1 P05556 1/20 0.31
ITGA4 P13612 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21002090 0.90 MMP1 (0.37) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21002092 0.90 MMP1 (0.37) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21034969 0.90 ADRB2 (0.40) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21036224 0.89 GHSR (0.41) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21036231 0.87 CHEK2 (0.40) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21035094 0.87 CHEK2 (0.40) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21036187 0.87 CHEK2 (0.40) MMP1MMP13MMP9MMP3MMP7
Trifluoroacetic Acid SCHEMBL21002039 0.87 MMP1 (0.37) MMP1MMP13MMP9MMP3MMP7
Trifluoroacetic Acid SCHEMBL21002157 0.87 MMP1 (0.37) MMP1MMP13MMP9MMP3MMP7
SCHEMBL21035360 0.86 MMP1 (0.38) MMP1MMP13MMP9MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed